Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-15
DOI
10.1038/s41388-018-0454-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer
- (2016) Tzu-Tang Wei et al. EBioMedicine
- DUSP1 Expression Induced by HDAC1 Inhibition Mediates Gefitinib Sensitivity in Non-Small Cell Lung Cancers
- (2015) Y.-C. Lin et al. CLINICAL CANCER RESEARCH
- ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
- (2015) S. Meidhof et al. EMBO Molecular Medicine
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
- (2015) Kenneth S Thress et al. NATURE MEDICINE
- Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer
- (2015) Lecia V. Sequist et al. NEW ENGLAND JOURNAL OF MEDICINE
- AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
- (2015) Pasi A. Jänne et al. NEW ENGLAND JOURNAL OF MEDICINE
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells
- (2013) K. Shien et al. CANCER RESEARCH
- Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs
- (2013) Jun Dou et al. CELL BIOLOGY INTERNATIONAL
- Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
- (2013) H. A. Yu et al. CLINICAL CANCER RESEARCH
- Design and Synthesis of Dual-Action Inhibitors Targeting Histone Deacetylases and 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase for Cancer Treatment
- (2013) Jhih-Bin Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents
- (2012) M. Thurnher et al. CLINICAL CANCER RESEARCH
- Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin
- (2012) Manjeet Mukherjee et al. EMBO JOURNAL
- Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
- (2012) Hasan Korkaya et al. MOLECULAR CELL
- MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
- (2011) Z. Cao et al. CANCER RESEARCH
- Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells
- (2011) Erika Pastrana et al. Cell Stem Cell
- Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis
- (2011) Shuji Mikami et al. LABORATORY INVESTIGATION
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Integration of Molecular Profiling into the Lung Cancer Clinic
- (2009) W. Pao et al. CLINICAL CANCER RESEARCH
- Novel Roles of Hakai in Cell Proliferation and Oncogenesis
- (2009) Angélica Figueroa et al. MOLECULAR BIOLOGY OF THE CELL
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- Statins Increase p21 through Inhibition of Histone Deacetylase Activity and Release of Promoter-Associated HDAC1/2
- (2008) Y.-C. Lin et al. CANCER RESEARCH
- Epithelial-Mesenchymal Transition and the Stem Cell Phenotype
- (2008) Derek C. Radisky et al. Cell Stem Cell
- Cancer Stem Cells in Breast: Current Opinion and Future Challenges
- (2008) Emmanuelle Charafe-Jauffret et al. PATHOBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started